Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?
Related Questions
Would you consider APBI in a patient who meets all criteria but has high-risk genomic testing and is not receiving chemotherapy?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Is stage I B/L breast, ER+ cancer a contraindication to breast radiation omission after breast conservation surgery?
Would you feel comfortable doing high tangents with ultra-hypofractionation?
Would you consider 5-fraction whole breast RT for a patient with multiple positive margins following lumpectomy for whom reexcision is not possible?
Would you offer prone APBI with IMRT/VMAT?
How would you approach a patient with a 12 mm recurrence of the left implant-based breast reconstruction 17 years after her initial diagnosis?
In what patients is it inappropriate to offer DCISionRT testing?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
What are your top takeaways in Breast Cancer from ASCO 2025?
